These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6300230)

  • 21. Uptake of liposomes and liposome-encapsulated muramyl dipeptide by human peripheral blood monocytes.
    Mehta K; Lopez-Berestein G; Hersh EM; Juliano RL
    J Reticuloendothel Soc; 1982 Aug; 32(2):155-64. PubMed ID: 7161762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG
    Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of pulmonary macrophage superoxide release and tumoricidal activity following activation by biological response modifiers.
    Drath DB
    Immunopharmacology; 1986 Oct; 12(2):117-26. PubMed ID: 3021650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Muramyl dipeptide derivatives in experimental and clinical use].
    Kaliuzhin OV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunomodulatory properties of new conjugates of muramyl dipeptide and nor-muramyl dipeptide with retro-tuftsin (Arg-Pro-Lys-Thr-OMe).
    Wardowska A; Dzierzbicka K; Trzonkowski P; Myśliwski A
    Int Immunopharmacol; 2006 Oct; 6(10):1560-8. PubMed ID: 16919828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal muramyl tripeptide upregulates adhesion molecules on the surface of human monocytes.
    Asano T; McIntyre BW; Bednarczyk JL; Wygant JN; Kleinerman ES
    Oncol Res; 1995; 7(5):253-7. PubMed ID: 8534931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposome encapsulation of muramyl peptides for activation of macrophage cytotoxic properties.
    Nayar R; Schroit AJ; Fidler IJ
    Methods Enzymol; 1986; 132():594-603. PubMed ID: 3547028
    [No Abstract]   [Full Text] [Related]  

  • 29. Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells.
    Koff WC; Fidler IJ; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
    Science; 1984 Jun; 224(4652):1007-9. PubMed ID: 6426057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of likopid--an immunomodulator in the combined treatment of patients with endometrial adenocarcinoma].
    Venediktova MG; Rumiantseva NK; Fedorova GV; Demidova MA; Zhilenko MI
    Vopr Onkol; 2001; 47(4):481-4. PubMed ID: 11710296
    [No Abstract]   [Full Text] [Related]  

  • 31. [The immunostimulating activity of muramyl dipeptide and its derivatives].
    Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients.
    Sone S; Utsugi T; Tandon P; Yanagawa H; Okubo A; Ogura T
    Cancer Immunol Immunother; 1990; 30(6):357-62. PubMed ID: 2302725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tuftsin--new analogues and properties].
    Wardowska A; Dzierzbicka K; Myśliwski A
    Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S; Fidler IJ
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species variability for toxicity of free and liposome-encapsulated muramyl peptides administered intravenously.
    Fidler IJ; Brown NO; Hart IR
    J Biol Response Mod; 1985 Jun; 4(3):298-309. PubMed ID: 4020387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis.
    Fidler IJ; Poste G
    Prog Clin Biol Res; 1981; 75B():257-67. PubMed ID: 7323097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.